Macrogenics (MGNX) Short-term Investments (2015 - 2019)

Macrogenics (MGNX) has 5 years of Short-term Investments data on file, last reported at $89.3 million in Q4 2019.

• Short-term Investments for Q4 2019 came in at $89.3 million, up 601.09% year-over-year; the trailing twelve-month figure through Dec 2019 was $89.3 million (up 601.09% YoY), and the FY2019 annual result was $89.3 million, up 601.09% from the prior year.
• Short-term Investments rose to $89.3 million in Q4 2019 per MGNX's latest filing, from $12.7 million in the prior quarter.
• Over five years, Short-term Investments peaked at $192.9 million in Q4 2016 and troughed at $12.7 million in Q4 2018.
• A 5-year average of $106.2 million and a median of $93.4 million in 2017 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2018 and 2019: Short-term Investments plunged 86.36% in 2018, then soared 601.09% in 2019.
• A 5-year view of Short-term Investments shows it stood at $142.9 million in 2015, then soared by 35.01% to $192.9 million in 2016, then tumbled by 51.58% to $93.4 million in 2017, then sank by 86.36% to $12.7 million in 2018, then soared by 601.09% to $89.3 million in 2019.
• Business Quant data shows MGNX's Short-term Investments at $89.3 million in Q4 2019, $12.7 million in Q4 2018, and $93.4 million in Q4 2017.